CPAP Preferentially Improves Cardiovascular Outcomes in High-Risk OSA

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 6, 2025.

via HealthDay

WEDNESDAY, Aug. 6, 2025 -- In patients with high-risk obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) improves cardiovascular outcomes, while harm may be seen in those with low-risk OSA, according to a study published online Aug. 5 in the European Heart Journal.

Ali Azarbarzin, Ph.D., from Harvard Medical School in Boston, and colleagues conducted a post-hoc analysis of randomized trials to examine whether the cardiovascular benefit of CPAP occurs preferentially in high-risk OSA, characterized by greater OSA-related heart rate acceleration or hypoxemia. The researchers examined the CPAP treatment effect on major adverse cardiovascular and cerebrovascular events (MACCE) for high-risk OSA and evaluated the difference versus low-risk OSA.

Overall, 16.6 and 16.3 percent of participants reached the MACCE end point with CPAP and usual care (1,778 and 1,771 participants, respectively). The researchers found that for participants with versus without high-risk OSA, the CPAP treatment effect was greater (interaction hazard ratio, 0.69). A stronger differential effect was seen for those without excessive sleepiness or without increased blood pressure (interaction hazard ratios, 0.59 and 0.54, respectively). Benefits of CPAP in high-risk OSA were seen alongside harm for those with low-risk OSA.

"For clinicians and policymakers, this means we may need to rethink current guidelines for treating nonsleepy patients and consider focusing treatment for cardiovascular risk reduction on those who stand to gain the most," Azarbarzin said in a statement. "We also need to be cautious about using CPAP in people who don't have high-risk markers, as they may not benefit and could even be harmed."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-07 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords